» Articles » PMID: 36355449

Single-dose Pharmacokinetics of Telmisartan Oral Solution and Effect of Feeding in Dogs

Overview
Specialty Pharmacology
Date 2022 Nov 10
PMID 36355449
Authors
Affiliations
Soon will be listed here.
Abstract

Telmisartan is an angiotensin II receptor blocker that has great potential to improve the treatment of hypertension, proteinuria, and cardiovascular disease in dogs. A feline-approved telmisartan oral solution (TOS) is available, but this formulation has not been evaluated in dogs. The aims of this study were to establish the pharmacokinetics of telmisartan administered as TOS and determine the effect of feeding on drug absorption in dogs. In a cross-over design, seven healthy dogs received 1 mg/kg telmisartan orally as TOS with or without food and underwent serial measurement of plasma telmisartan concentrations over 24 h. Bioequivalence of TOS administered with vs. without food was assessed by the 90% confidence interval method for maximum concentration (C ), and the observed and extrapolated areas under the curve (AUC and AUC ). The mean ratios of these parameters were 0.97 (CI 0.74-1.27), 0.92 (0.81-1.03), and 0.90 (0.82-1.00), respectively. Feeding methods were not bioequivalent based on C due to interindividual variation. These results suggest that TOS can be given to dogs with or without food but should be administered in the same way consistently. Additional pharmacokinetic and pharmacodynamic studies are warranted to confirm this recommendation and establish the therapeutic targets for telmisartan in dogs.

Citing Articles

Single-dose pharmacokinetics of telmisartan oral solution and effect of feeding in dogs.

Bechtel A, Reinhart J, Li Z J Vet Pharmacol Ther. 2022; 46(1):17-24.

PMID: 36355449 PMC: 10098839. DOI: 10.1111/jvp.13104.

References
1.
Ebner T, Schanzle G, Weber W, Sent U, Elliott J . In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species. J Vet Pharmacol Ther. 2012; 36(2):154-60. DOI: 10.1111/j.1365-2885.2012.01398.x. View

2.
Jenkins T, Coleman A, Schmiedt C, Brown S . Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats. Am J Vet Res. 2015; 76(9):807-13. DOI: 10.2460/ajvr.76.9.807. View

3.
Acierno M, Brown S, Coleman A, Jepson R, Papich M, Stepien R . ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018; 32(6):1803-1822. PMC: 6271319. DOI: 10.1111/jvim.15331. View

4.
Wang B, Sheng L, Li Y . Simultaneous determination of telmisartan and amlodipine in dog plasma by LC-MS-MS. J Chromatogr Sci. 2015; 53(10):1708-13. DOI: 10.1093/chromsci/bmv078. View

5.
Brown S, Elliott J, Francey T, Polzin D, Vaden S . Consensus recommendations for standard therapy of glomerular disease in dogs. J Vet Intern Med. 2014; 27 Suppl 1:S27-43. DOI: 10.1111/jvim.12230. View